Kardiovita - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 510,054 | 568,746 | 513,413 | 648,793 | 806,057 | 1,184,422 | 1,361,327 | 569,029 |
| Profit before tax | 279,192 | 302,833 | 340,688 | - | - | - | - | - |
| Net profit | 278,511 | 301,990 | 333,289 | 371,414 | 486,932 | 670,074 | 735,206 | 107,987 |
| Equity | 381,504 | 277,612 | 124,711 | 374,600 | 508,591 | 590,431 | 1,325,636 | 434,568 |
| Liabilities | 3,437 | 3,266 | 9,220 | 11,463 | 14,406 | 9,506 | 11,798 | 21,277 |
| Non-current assets | 13,750 | 57,999 | 42,250 | 28,348 | 14,791 | 21,975 | 70,203 | 55,726 |
| Current assets | 371,191 | 222,879 | 91,681 | 357,715 | 508,206 | 577,243 | 1,270,037 | 402,260 |
| Total assets | 384,941 | 280,878 | 133,931 | 386,063 | 522,997 | 599,218 | 1,340,240 | 457,986 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 159,115 | 96,922 | 214,556 |
| Social insurance contributions | - | - | - | - | - | 80,926 | 98,125 | 74,131 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +21.5% | +11.5% | -9.7% | +26.4% | +24.2% | +46.9% | +14.9% | -58.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 72.4% | 107.5% | 248.9% | 96.2% | 93.1% | 111.8% | 54.9% | 23.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 73.0% | 108.8% | 267.2% | 99.1% | 95.7% | 113.5% | 55.5% | 24.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 54.6% | 53.1% | 64.9% | 57.2% | 60.4% | 56.6% | 54.0% | 19.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 54.7% | 53.2% | 66.4% | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 63,757 | 71,841 | 64,177 | 81,099 | 101,817 | 140,723 | 152,672 | 65,032 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Kardiovita - Social security debts
The company had no debts to Sodra
Kardiovita - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-05-20 | 2025-05-20 | 5034.71 |
| 2025-05-07 | 2025-05-19 | 4988.81 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Kardiovita, UAB (code 302561031) is a Private Limited Liability Company engaged in medical specialists activities. In 2025, the company generated revenue of €569.0K and net profit of €108.0K, corresponding to a profit margin of 19.0%. This marked a clear decline from 2024, when revenue reached €1.36M and net profit €735.2K, after a solid 2023 result of €1.18M in revenue and €670.1K in profit. Over the two-year period, revenue decreased by 52.0%, and year-on-year revenue growth in 2025 was -58.2%. The profitability trend was also weaker in 2025, although the company remained profitable. At the end of 2025, total assets stood at €458.0K, equity at €434.6K, and liabilities at €21.3K, indicating a very strong equity position with an equity ratio of 94.9% and debt-to-equity of 0.05. Asset turnover was 1.24x, ROE was 24.9%, and ROA was 23.6%. Revenue per employee was €71.1K and profit per employee €13.5K.